ELTS Score (EUTOS Long-Term Survival)

ورودی‌های بالینی بیمار

حداقل ۱۵ — حداکثر ۱۰۰ • واحد: years

حداقل ۰ — حداکثر ۴۰ • واحد: cm

حداقل ۰ — حداکثر ۱۰۰ • واحد: %

حداقل ۱۰ — حداکثر ۳۰۰۰ • واحد: x10^9/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
elts
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • low≤ 1.568
  • intermediate1.568–2.2185
  • high≥ 2.2185
Direct Clinical Answer

The ELTS Score (EUTOS Long-Term Survival) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include age years. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

CML long-term survival risk score.

Clinical Indication

The ELTS Score (EUTOS Long-Term Survival) is indicated for bedside clinical practice to support CML long-term survival risk score.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

ELTS = 0.0025x(age/10)^3 + 0.0615xspleen + 0.1052xblasts + 0.4104x(platelets/1000)^-0.5

Input Parameters

NameTypeRequiredDescription
age_yearsintegerYesAge(years)
spleen_cmfloatYesSpleen size below costal margin(cm)
blasts_percentfloatYesPeripheral blood blasts(%)
platelets_x1e9_lfloatYesPlatelets(x10^9/L)

Score Interpretation & Guidance

RangeStageDescription
≤ 1.568lowLow risk
1.568–2.2185intermediateIntermediate risk
≥ 2.2185highHigh risk

Evidence-Based References (EBM)

  • Pfirrmann M, et al. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia. 2016;30(1):48-56.

Related calculators